Chaim Hurvitz

Chairman of The Board

Chaim has served as CEO of CH Health, a healthcare focused venture capital firm, since May 2011. He was previously a member of Teva’s senior management, serving as the President of Teva International Group from 2002-2010, Vice President of Israeli Pharmaceutical Sales from 1999-2002 and President and CEO of Teva Pharmaceuticals Europe from 1992-1999. Chaim presently serves as a director in various healthcare companies and is also a member of management of the Manufacturers Association of Israel and Head of its Pharmaceutical branch. His investments through CH Health have included several successful exits including the NASDAQ IPOs of Galmed (GLMD) and Urogen (URGN).

Eliyahu (Lee) Haddad

CEO

Lee is a multi-disciplinary finance and technology expert, with extensive senior level operational experience in raising capital, growing complex business models, and guiding startups and later stage companies to successful exits. Over the course of his 30-year career, Lee has structured and managed over $85bn of deals in technology and media, including $250 million in transactions within the Israeli high-tech space in AI, medical technology, and cybersecurity. Mr. Haddad has 15 years of C-Level experience in running technology companies in the B2B, B2B2C, and B2C areas with employees ranging from 20 to 450. Lee was educated at Columbia University, and was the winner of the National Science Foundation Award in Theoretical Physics as a senior in high school. Mr. Haddad started his career in the M&A group of Morgan Stanley’s media and technology group for several years after being the head of acquisitions and business development for Time, Inc. one of the largest media companies in the world.

Moshe Shvets

CTO

Educated in Saint Petersburg University of Aerospace Instrumentation, Moshe comes to Dror as a seasoned senior executive with 25 years of experience in building companies with over 250M € yearly revenues that involve complex instrumentation & processes, regulation, software, and global infrastructure. With the sale of his TIER I automotive instrumentation company to Federal Mogul (Carl Ichan Foundation subsidiary ), he demonstrated his ability to bring shareholder value. Before joining the management team, Moshe was one of the investors in the company and is also a member of the Board of Directors.

AI & Software Development Team

The company’s outsourced development team is composed of 8 professionals with years of experience in AI development, data science, application and software engineering. The team comes from the most elite intelligence units in the Israeli Defense Force and have worked on advanced projects ranging from computer vision, imaging, and targeting systems development.

Yossi Avni
Head of Software Platform Development

After completing his service in an elite military unit of the IDF, Yossi received a BSc in applied mathematics from the Israeli Technion in Haifa. Yossi has 25 years of experience in developing advanced artificial Intelligence applications, behavioral biometrics, behavioral profiling, and advanced security systems. Mr. Avni holds over 100 patents in these areas and has expertise in next-generation machine learning, neural networks, intelligent machine-human collaboration, and computational studies of the brain – with application to AI, data science, and high-tech industry.  Yossi’s mentor who he has also consulted with the development of the Zsmile platform is Prof. Hava Siegelmann who is internationally known University of Massachusetts Provost Professor in Computer Science and a recognized expert in neural networks. She lectures to advanced graduate students at Harvard University and MIT.   Yossi has been involved with work in computation beyond the Turing limit, and for achieving advanced learning capabilities through a new type of AI. Prof. Siegelmann is the co-inventor of the Support Vector Clustering (SVC) algorithm, which is widely used across industry and government. Mr. Avni is the CTO of Soda Ltd. Software Outsourcing Development & Architecture, managing a team of 11 core employees with an additional 40 freelancers, focused on providing development services to Zsmile.

Hardware Development Team

The company’s hardware development team is composed of 6 professionals with years of experience in FDA – compliant medical device development. They are part of Aran Research Development & Prototypes Ltd. Founded in 1982. Aran is a leading Israeli product design and development firm and an exclusive agent of global equipment manufacturers for the plastics industry. Aran is publicly traded on the Tel Aviv Stock Exchange. Aran provides comprehensive medical device development and production services, all the way from conceptual inception to market-ready product – including specification, risk management, system engineering, development, V&V, serial production and supply (FDA registered). Their creative teams of experts – designers, mechanical, software and electrical engineers – successfully developed a wide range of medical devices, communications and monitoring, as well as military devices. Aran is ISO 13485 certified and maintains a class 7 cleanroom for testing and assembly.  As our hardware development partner, Aran also has manufacturing facilities and a full suite of 3D printing capabilities, which are all under FDA guidelines.

Avi Kayton
Head of Hardware & Systems Development

Avi is a skilled development manager and systems engineer with 16 years of experience, with extensive experience in medical device companies. Experienced in managing medical projects throughout their entire life cycle, including managing multidisciplinary teams and subcontractors. After completing his military service in the IDF as a practical engineer dealing with computerized monitoring and control systems, Mr. Kayton received his B.Sc. In Electrical Engineering from the Holon Institute of Technology. Avi currently is Head of medical projects department of Aran and is in charge of all medical device development, design, and manufacturing. Avi brings together all of the teams of experts from within Aran to service the Company’s development needs – teams from materials experts, industrial design, 3D printing, mechanical and electrical engineering, etc.

Working with top orthodontal experts

Dr. Chung H. Kau

B.D.S., M.Sc. D., M.B.A., Ph.D

Zsmile Senior Scientific Orthodontal Advisor

  • Conducted clinical trials for FDA approval of Zsmile System
  • Expertise in dental imaging and tooth movement
  • Oversees Zsmile R&D team

Professor and Chair at the Department of Orthodontics, University of Alabama at Birmingham

He also holds academic appointments as Senior Scientist at the Global Center for Craniofacial, Oral and Dental Disorders and UAB Microbiome Center. He is a Diplomate of the American Board of Orthodontics(US), Specialist Orthodontist on the Singapore Dental Council and the General Dental Council (United Kingdom). He enjoys practicing clinical orthodontics has a special interest in craniofacial anomalies and dento-facial deformities. He is also a researcher with a keen interest in clinical translational research focusing on technology driven orthodontic applications, dent-facial deformities, juvenile idiopathic arthritis, accelerated tooth movement and 4D jaw tracking.  In 2011, he was awarded the King James IV Professor by the Royal College of Surgeons of Edinburgh where he also served as the International Advisor for the USA and examiner for the MFDS and Morth examinations.